Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 54076 - 54100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Oxaliplatin	Approved Investigational	S100A14	57402	upregulated	oxaliplatin results in increased expression of S100A14 mRNA	1q21.3	A22638
Oxaliplatin	Approved Investigational	S100A4	6275	upregulated	oxaliplatin results in increased expression of S100A4 mRNA	1q21.3	A22638
Oxaliplatin	Approved Investigational	S100P	6286	downregulated	oxaliplatin results in decreased expression of S100P mRNA	4p16.1	A23409
Oxaliplatin	Approved Investigational	SAT1	6303	upregulated	oxaliplatin results in increased expression of SAT1 mRNA	Xp22.11	A22640 A22638 A22674
Oxaliplatin	Approved Investigational	SDC1	6382	upregulated	oxaliplatin results in increased expression of SDC1 mRNA	2p24.1	A23409
Oxaliplatin	Approved Investigational	SDHB	6390	downregulated	oxaliplatin results in decreased expression of SDHB mRNA	1p36.13	A23409
Oxaliplatin	Approved Investigational	SENP1	29843	downregulated	oxaliplatin results in decreased expression of SENP1 mRNA	12q13.11	A23409
Oxaliplatin	Approved Investigational	SERPINH1	871	downregulated	oxaliplatin results in decreased expression of SERPINH1 mRNA	11q13.5	A22638
Oxaliplatin	Approved Investigational	SH2B3	10019	downregulated	oxaliplatin results in decreased expression of SH2B3 mRNA	12q24.12	A23409
Oxaliplatin	Approved Investigational	SLC2A3	6515	downregulated	oxaliplatin results in decreased expression of SLC2A3 mRNA	12p13.31	A23409
Oxaliplatin	Approved Investigational	SLC38A1	81539	downregulated	oxaliplatin results in decreased expression of SLC38A1 mRNA	12q13.11	A22638
Oxaliplatin	Approved Investigational	SLC7A5	8140	downregulated	oxaliplatin results in decreased expression of SLC7A5 mRNA	16q24.2	A23409
Oxaliplatin	Approved Investigational	SOX4	6659	upregulated	oxaliplatin results in increased expression of SOX4 mRNA	6p22.3	A22638
Oxaliplatin	Approved Investigational	SPTBN1	6711	upregulated	oxaliplatin results in increased expression of SPTBN1 mRNA	2p16.2	A23409
Oxaliplatin	Approved Investigational	SRP72	6731	downregulated	oxaliplatin results in decreased expression of SRP72 mRNA	4q12	A23409
Oxaliplatin	Approved Investigational	SRPK1	6732	upregulated	oxaliplatin results in increased expression of SRPK1 mRNA	6p21.31	A23410
Oxaliplatin	Approved Investigational	STC1	6781	downregulated	oxaliplatin results in decreased expression of STC1 mRNA	8p21.2	A23409
Oxaliplatin	Approved Investigational	STK17A	9263	downregulated	oxaliplatin results in decreased expression of STK17A mRNA	7p13	A23409
Oxaliplatin	Approved Investigational	TGIF1	7050	downregulated	oxaliplatin results in decreased expression of TGIF1 mRNA	18p11.31	A23409
Oxaliplatin	Approved Investigational	TMSB10	9168	upregulated	oxaliplatin results in increased expression of TMSB10 mRNA	2p11.2	A22640
Oxaliplatin	Approved Investigational	TNIK	23043	upregulated	oxaliplatin results in increased expression of TNIK mRNA	3q26.2-q26.31	A22638
Oxaliplatin	Approved Investigational	TSPO	706	downregulated	oxaliplatin results in decreased expression of TSPO mRNA	22q13.2	A23409
Oxaliplatin	Approved Investigational	TYMS	7298	downregulated	oxaliplatin results in decreased expression of TYMS mRNA	18p11.32	A23414
Oxaliplatin	Approved Investigational	VEGFA	7422	upregulated	oxaliplatin results in increased expression of VEGFA mRNA	6p21.1	A23415
Oxaliplatin	Approved Investigational	ZBTB18	10472	upregulated	oxaliplatin results in increased expression of ZBTB18 mRNA	1q44	A22638

Displaying entries 54076 - 54100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability